Authors: Fontaine, E Riva, C Peeters, M Schmit, JC Delaporte, E Van Laethem, K Van Vaerenbergh, K Snoeck, J Van Wijngaerden, E De Clercq, E Van Ranst, M Vandamme, AM

Citation: E. Fontaine et al., Evaluation of two commercial kits for the detection of genotypic drug resistance on a panel of HIV type 1 subtypes A through J, J ACQ IMM D, 28(3), 2001, pp. 254-258

Authors: Van Vaerenbergh, K Debaisieux, L De Cabooter, N Declercq, C Desmet, K Fransen, K Maes, B Marissens, D Miller, K Muyldermans, G Sprecher, S Stuyver, L Vaira, D Verhofstede, C Zissis, G Van Ranst, M De Clercq, E Desmyter, J Vandamme, AM

Citation: K. Van Vaerenbergh et al., Prevalence of genotypic resistance among antiretroviral drug-naive HTV-1-infected patients in Belgium, ANTIVIR TH, 6(1), 2001, pp. 63-70

Authors: Van Vaerenbergh, K Van Laethem, K Van Wijngaerden, E Schmit, JC Schneider, F Ruiz, L Clotet, B Verhofstede, C Van Wanzeele, F Muyldermans, G Simons, P Stuyver, L Hermans, P Evans, C De Clercq, E Desmyter, J Vandamme, AM

Citation: K. Van Vaerenbergh et al., Baseline HIV type 1 genotypic resistance to a newly added nucleoside analog is predictive of virologic failure of the new therapy, AIDS RES H, 16(6), 2000, pp. 529-537

Authors: Van Vaerenbergh, K Van Laethem, K Albert, J Boucher, CAB Clotet, B Floridia, M Gerstoft, J Hejdeman, B Nielsen, C Pannecouque, C Perrin, L Pirillo, MF Ruiz, L Schmit, JC Schneider, F Schoolmeester, A Schuurman, R Stellbrink, HJ Stuyver, L Van Lunzen, J Van Remoortel, B Van Wijngaerden, E Vella, S Witvrouw, M Yerly, S De Clercq, E Desmyter, J Vandamme, AM

Citation: K. Van Vaerenbergh et al., Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues, ANTIM AG CH, 44(8), 2000, pp. 2109-2117

Authors: Van Laethem, K Van Vaerenbergh, K Schmit, JC Sprecher, S Hermans, P De Vroey, V Schuurman, R Harrer, T Witvrouw, M Van Wijngaerden, E Stuyver, L Van Ranst, M Desmyter, J De Clercq, E Vandamme, AM

Citation: K. Van Laethem et al., Phenotypic assays and sequencing are less sensitive than point mutation assays for detection of resistance in mixed HIV-1 genotypic populations, J ACQ IMM D, 22(2), 1999, pp. 107-118